Who owns Inhibitex?
Key information on Inhibitex (Ticker: INHX)
- CUSIP: 45719T103
Who owns Inhibitex?
Is INHX a good stock to own? Find out who bought Inhibitex, who sold Inhibitex (INHX) stock, and who holds a large position in Inhibitex.
- HealthCor Management owns 2.05M shares worth $22.43M
- Adage Capital Partners GP owns 2.03M shares worth $22.18M
- RA Capital Management owns 1.96M shares worth $21.44M
- Bridger Management owns 1.60M shares worth $17.51M
- Oxford Asset Management owns 1.26M shares worth $13.76M
- STATE STREET CORPORATION owns 1.19M shares worth $13.00M
- OrbiMed Advisors owns 1.14M shares worth $12.45M
- Wellington Management Company owns 987822 shares worth $10.81M
- S.A.C. Capital Advisors owns 961188 shares worth $10.52M
- CITADEL ADVISORS owns 887564 shares worth $9.71M
- Insight Capital Research & Management owns 816298 shares worth $8.93M
- OppenheimerFunds owns 727130 shares worth $7.95M
- Franklin Resources owns 653935 shares worth $7.15M
- Jennison Associates owns 586000 shares worth $6.41M
- Millennium Management owns 573752 shares worth $6.28M
- Hambrecht & Quist Capital Management owns 544109 shares worth $5.95M
- Redmile owns 513000 shares worth $5.61M
- Barclays owns 484667 shares worth $5.30M
- Kingdon Capital Management owns 455000 shares worth $4.97M
- Driehaus Capital Management owns 444826 shares worth $4.87M
- HIGHBRIDGE CAPITAL MANAGEMENT owns 418946 shares worth $4.58M
- Perella Weinberg Partners Capital Management owns 408200 shares worth $4.47M
- Partner Fund Management owns 405007 shares worth $4.43M
- Emerald Advisers owns 350869 shares worth $3.84M
- Thomas Weisel Asset Management owns 314247 shares worth $3.44M
- Visium Asset Management owns 300000 shares worth $3.28M
- Technical Financial Services owns 282454 shares worth $3.09M
- Renaissance Technologies owns 270200 shares worth $2.96M
- TIAA-CREF Investment Management owns 264123 shares worth $2.89M
- 1798 Global Partners owns 219300 shares worth $2.40M
- Geode Capital Management owns 213066 shares worth $2.33M
- Hutchin Hill Capital owns 210000 shares worth $2.30M
- QVT Financial owns 202406 shares worth $2.21M
- Two Sigma Investments owns 177816 shares worth $1.95M
- RCM Capital Management owns 166012 shares worth $1.82M
- Soros Fund Management owns 150000 shares worth $1.64M
- Emerald Mutual Fund Advisers, Trust owns 145540 shares worth $1.59M
- ALLIANCEBERNSTEIN owns 135700 shares worth $1.48M
- NUMERIC INVESTORS owns 125400 shares worth $1.37M
- CalPERS owns 122600 shares worth $1.34M
- Diamondback Capital Management owns 111860 shares worth $1.22M
- Charles Schwab Investment Management owns 89200 shares worth $975848
- GOLDMAN SACHS owns 84562 shares worth $925108
- BAM Capital owns 80329 shares worth $197609
- Frank Russell Company owns 76327 shares worth $811356
- RHUMBLINE ADVISERS owns 65499 shares worth $717214
- Teachers Advisors owns 62381 shares worth $681824
- AQR Capital Management owns 60300 shares worth $660285
- WEISS MULTI-STRATEGY ADVISERS owns 60000 shares worth $657600
- WEISS MULTI-STRATEGY ADVISERS owns 60000 shares worth $657600
Who sold Inhibitex?
- Vanguard sold on Sept. 30, 2011
- Eudaimonia Asset Management sold on Sept. 30, 2011
- Suffolk Capital Management sold on Sept. 30, 2011
- Partner Investment Management sold on Sept. 30, 2011
- BBT Capital Management sold on Sept. 30, 2011
- Shell Asset Management Company sold on Sept. 30, 2011
- MOORE CAPITAL MANAGEMENT sold on Sept. 30, 2011
- NEA Management Company sold on June 30, 2011
- Baker Bros. Advisors sold on June 30, 2011
- GRT Capital Partners sold on June 30, 2011
- Bank of America Corporation sold on March 31, 2011
- FMR sold on Dec. 31, 2010
- Manulife Asset Management sold on March 31, 2006
Funds that own INHX also own:
- Cognizant Technology Solutions (CTSH)
- Corning Incorporated (GLW)
- Goldman Sachs (GS)
- Abbott Laboratories (ABT)
- Baxter International (BAX)
- Cardinal Health (CAH)
- Universal Health Services (UHS)
- Thermo Fisher Scientific (TMO)
- Aetna (AET)
- Health Management Associates (HMA)
- CareFusion Corporation (CFN)
- WellPoint (WLP)
- Biogen Idec (BIIB)
- Gilead Sciences (GILD)
- Mead Johnson Nutrition (MJN)
- Humana (HUM)
- Watson Pharmaceuticals (WPI)
- Salix Pharmaceuticals (SLXP)
- St. Jude Medical (STJ)
- Ariad Pharmaceuticals (ARIA)
- Inhibitex (INHX)